NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast of Editas Medicine Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Editas Medicine EDIT at this time. Stock is rising and might rise more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.

My analysis of Editas Medicine is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Editas Medicine stays above 2.9, but if it comes below 2.9, then a intra day sell could be more profitable.
If you take a sell trade below 2.9, then use 2.9 as stoploss and 2.82 as target. However if you take a buy trade in Editas Medicine, then use 2.9 as stoploss and 3.1 as target.

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

Tata Capital's revolving credit exposure below 5% of loan book: Sabharwal Lender to submit feedback on RBI proposal to bar NBFCs from offering revolving credit products - NEWS as on 2026-08-11 business-standard.com

Increasing your credit card limit is a risk and reward: How to do it safely Treating a higher limit as extra income rather than a deferred payment is a dangerous habit - NEWS as on 2026-08-09 business-standard.com

NBFC loan growth reaches 14.4% by June, led by retail credit expansion Gold loans expanded 69.3 per cent and consumer durables credit grew 46.8 per cent, helping lift retail loans by 20.3 per cent to Rs 25.6 trillion by the end of June 2026 - NEWS as on 2026-08-07 business-standard.com

SBI sees broad-based credit growth, sticks to 14-15% FY27 loan growth guidance State Bank of India expects credit growth to remain broad-based across segments. The bank retained its loan growth guidance at fourteen to fifteen percent. It also anticipates mobilising around ten billion dollars in foreign-currency deposits. Net interest - NEWS as on 2026-08-07 indiatimes.com

Global Market: Oracle's AI spending spree pushes credit rating to brink of junk status Oracle's debt-funded AI expansion has intensified concerns over its financial health, with rating agencies warning of rising leverage as the company moves closer to junk status despite strong revenue growth. - NEWS as on 2026-08-05 indiatimes.com

Lack of proper training in credit monitoring among reasons for frauds: CVC to banks The Central Vigilance Commission has advised banks on training to prevent frauds. Lack of proper credit appraisal and monitoring is identified as a key reason for these issues. Banks and financial institutions are urged to conduct training programs focusin - NEWS as on 2026-08-04 indiatimes.com

India's bank credit growth remains robust at 18.6% in June 2026; NBFC, retail lending drive momentum: Report India's average bank credit growth remained robust in June 2026, supported by healthy retail lending and strong credit flow to non-banking financial companies (NBFCs) and commercial real estate (CRE), according to a report by Haitong Securities India. - NEWS as on 2026-08-03 indiatimes.com

Formal retail credit access doubles over past decade India’s formal retail credit market has expanded sharply over the past decade, with credit access rising from 35% of consumers in 2017 to 74% in 2026, according to TransUnion CIBIL. Consumption-led loans such as personal loans, credit cards and consumer du - NEWS as on 2026-07-31 indiatimes.com

AI Big Short? Why rising credit default swaps are spooking investors and how is it similar to 2008 housing crisis Rising credit default swaps on major technology companies are fuelling concerns over a potential AI-driven market correction. Investors are drawing parallels with Michael Burry’s successful 2008 bet, while surging AI spending, leverage and elevated valuati - NEWS as on 2026-07-30 indiatimes.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Share on: WhatsApp Facebook Tweet